Literature DB >> 32415834

Temporal Confounding in the Test-Negative Design.

Natalie E Dean, M Elizabeth Halloran, Ira M Longini.   

Abstract

In the test-negative design, routine testing at health-care facilities is leveraged to estimate the effectiveness of an intervention such as a vaccine. The odds of vaccination for individuals who test positive for a target pathogen is compared with the odds of vaccination for individuals who test negative for that pathogen, adjusting for key confounders. The design is rapidly growing in popularity, but many open questions remain about its properties. In this paper, we examine temporal confounding by generalizing derivations to allow for time-varying vaccine status, including out-of-season controls, and open populations. We confirm that calendar time is an important confounder when vaccine status varies during the study. We demonstrate that, where time is not a confounder, including out-of-season controls can improve precision. We generalize these results to open populations. We use our theoretical findings to interpret 3 recent papers utilizing the test-negative design. Through careful examination of the theoretical properties of this study design, we provide key insights that can directly inform the implementation and analysis of future test-negative studies.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords:  case-control studies; confounding factors; seasonal variation; test-negative design; vaccination

Mesh:

Year:  2020        PMID: 32415834      PMCID: PMC7604521          DOI: 10.1093/aje/kwaa084

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  Variable definitions of the influenza season and their impact on vaccine effectiveness estimates.

Authors:  Sheena G Sullivan; Ee Laine Tay; Heath Kelly
Journal:  Vaccine       Date:  2013-07-09       Impact factor: 3.641

2.  Is it necessary to adjust for calendar time in a test negative design?: Responding to: Jackson ML, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8.

Authors:  Peter Jacoby; Heath Kelly
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

3.  Invited Commentary: Beware the Test-Negative Design.

Authors:  Daniel Westreich; Michael G Hudgens
Journal:  Am J Epidemiol       Date:  2016-09-01       Impact factor: 4.897

4.  Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Authors:  Sheena G Sullivan; Eric J Tchetgen Tchetgen; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2016-09-01       Impact factor: 4.897

5.  The test-negative design for estimating influenza vaccine effectiveness.

Authors:  Michael L Jackson; Jennifer C Nelson
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

6.  Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.

Authors:  C V Broome; R R Facklam; D W Fraser
Journal:  N Engl J Med       Date:  1980-09-04       Impact factor: 91.245

7.  Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions.

Authors:  Katherine L Anders; Zoe Cutcher; Immo Kleinschmidt; Christl A Donnelly; Neil M Ferguson; Citra Indriani; Peter A Ryan; Scott L O'Neill; Nicholas P Jewell; Cameron P Simmons
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

8.  Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.

Authors:  Marie R Griffin; Arnold S Monto; Edward A Belongia; John J Treanor; Qingxia Chen; Jufu Chen; H Keipp Talbot; Suzanne E Ohmit; Laura A Coleman; Gerry Lofthus; Joshua G Petrie; Jennifer K Meece; Caroline Breese Hall; John V Williams; Paul Gargiullo; LaShondra Berman; David K Shay
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

9.  Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.

Authors:  Lauren M Schwartz; M Elizabeth Halloran; Ali Rowhani-Rahbar; Kathleen M Neuzil; John C Victor
Journal:  Vaccine       Date:  2016-11-18       Impact factor: 3.641

10.  The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.

Authors:  Ivo M Foppa; Jill M Ferdinands; Sandra S Chaves; Michael J Haber; Sue B Reynolds; Brendan Flannery; Alicia M Fry
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

View more
  2 in total

Review 1.  The variants of SARS-CoV-2 and the challenges of vaccines.

Authors:  Xiucui Han; Qing Ye
Journal:  J Med Virol       Date:  2021-12-15       Impact factor: 20.693

2.  SARS-CoV-2 Variants and Vaccines.

Authors:  Philip R Krause; Thomas R Fleming; Ira M Longini; Richard Peto; Sylvie Briand; David L Heymann; Valerie Beral; Matthew D Snape; Helen Rees; Alba-Maria Ropero; Ran D Balicer; Jakob P Cramer; César Muñoz-Fontela; Marion Gruber; Rogerio Gaspar; Jerome A Singh; Kanta Subbarao; Maria D Van Kerkhove; Soumya Swaminathan; Michael J Ryan; Ana-Maria Henao-Restrepo
Journal:  N Engl J Med       Date:  2021-06-23       Impact factor: 176.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.